Radiation response of glioblastoma cells upon treatment with BV6 and radiation
Cell line treatment | Plating efficiency [%] | α [Gy−1] | β [Gy−2] | LD50 [Gy] | Radiation enhancement ratio | LD10 [Gy] | Radiation enhancement ratio |
---|---|---|---|---|---|---|---|
A172 | |||||||
Mock treated | 32.4 | 0.2274 | 0.0178 | 2.54 | 6.66 | ||
DMSO treated | 28.6 | 0.1813 | 0.0232 | 2.81 | 6.79 | ||
BV6 [1.5 μmol/L] | 1.1 | 0.0000 | 1.1488 | 0.78 | 3.62 | 1.42 | 4.80 |
T98G | |||||||
Mock treated | 15.7 | 0.2142 | 0.0029 | 3.11 | 9.53 | ||
DMSO treated | 16.0 | 0.1984 | 0.0050 | 3.23 | 9.39 | ||
BV6 [1.5 μmol/L] | 6.2 | 0.2738 | 0.0045 | 2.43 | 1.33 | 7.49 | 1.25 |
U87MG | |||||||
Mock treated | 14.2 | 0.2371 | 0.0067 | 2.72 | 7.94 | ||
DMSO treated | 13.9 | 0.2224 | 0.0080 | 2.83 | 8.03 | ||
BV6 [1.5 μmol/L] | 8.0 | 0.1905 | 0.0146 | 2.96 | 0.95 | 7.63 | 1.05 |
NOTE: Radiation enhancement ratios at 50% (LD50) and 10% survival (LD10) were calculated by transforming the linear quadratic equation (SF = exp [−α × D − β × D2]) using α and β values of the individual survival curves.